XW03377 ICD-10-PCS Code: Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7
Introduce Trilaciclib in Periph Vein, Perc, New Tech 7
Axis Breakdown
Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.
| Position | Value | Meaning |
|---|---|---|
| 1 | SectionX | New Technology |
| 2 | Body SystemW | Anatomical Regions |
| 3 | Root Operation0 | Introduction Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products |
| 4 | Body Part3 | Peripheral Vein |
| 5 | Approach3 | Percutaneous |
| 6 | Device / Substance / Technology7 | Trilaciclib |
| 7 | New Technology Group7 | New Technology Group 7 |
Related Codes
Same operation — other Body Part
Same table and root operation, differing only in the body part character.
Same operation — other Device
Same table and root operation, differing only in the device character.
XW03357 — Introduction of Narsoplimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW03367 — Introduction of Terlipressin into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW03387 — Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW033A7 — Introduction of Ciltacabtagene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW033B7 — Introduction of Amivantamab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW033C7 — Introduction of Autologous Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW033G7 — Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW033H7 — Introduction of Axicabtagene Ciloleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7, +5 more
Same operation — other Qualifier
Same table and root operation, differing only in the qualifier character.
XW03372 — Introduction of Inactivated Coagulation Factor Xa into Peripheral Vein, Percutaneous Approach, New Technology Group 2, XW03378 — Introduction of Tabelecleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW0337C — Introduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 12
Same procedure category (CCSR), other tables
AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration of therapeutic substances, NEC (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.
3E0U3TZ — Introduction of Destructive Agent into Joints, Percutaneous Approach, 3E0U4GC — Introduction of Other Therapeutic Substance into Joints, Percutaneous Endoscopic Approach, 3E0V0GB — Introduction of Recombinant Bone Morphogenetic Protein into Bones, Open Approach, 3E0V0GC — Introduction of Other Therapeutic Substance into Bones, Open Approach, 3E0V3GB — Introduction of Recombinant Bone Morphogenetic Protein into Bones, Percutaneous Approach, 3E0V3GC — Introduction of Other Therapeutic Substance into Bones, Percutaneous Approach, 3E0V3TZ — Introduction of Destructive Agent into Bones, Percutaneous Approach, 3E0V4GC — Introduction of Other Therapeutic Substance into Bones, Percutaneous Endoscopic Approach, 3E0W3GC — Introduction of Other Therapeutic Substance into Lymphatics, Percutaneous Approach, 3E0W3TZ — Introduction of Destructive Agent into Lymphatics, Percutaneous Approach, 3E0X3GC — Introduction of Other Therapeutic Substance into Cranial Nerves, Percutaneous Approach, 3E0X3TZ — Introduction of Destructive Agent into Cranial Nerves, Percutaneous Approach, 3E0Y3GC — Introduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Approach, 3E0Y3SF — Introduction of Other Gas into Pericardial Cavity, Percutaneous Approach, 3E0Y3TZ — Introduction of Destructive Agent into Pericardial Cavity, Percutaneous Approach, 3E0Y4GC — Introduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Endoscopic Approach, 3E0Y7SF — Introduction of Other Gas into Pericardial Cavity, Via Natural or Artificial Opening, XY0VX83 — Extracorporeal Introduction of Endothelial Damage Inhibitor to Vein Graft, New Technology Group 3, XY0YX28 — Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8, XY0YX37 — Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7, +213 more
Contextual Map
Every relationship of XW03377 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
PCS table
- XW0[PCS table]— CMS ICD-10-PCS tables
- New Technology — Section: New Technology[Section]: “New Technology”— CMS ICD-10-PCS tables
- Anatomical Regions — Body System: Anatomical Regions[Body System]: “Anatomical Regions”— CMS ICD-10-PCS tables
- Introduction — Operation: Introduction[Operation]: “Introduction”— CMS ICD-10-PCS tables
Clinical classification (CCSR)
- ADM021 — Administration of therapeutic substances, NEC[CCSR category]: “Administration of therapeutic substances, NEC — Administration of Therapeutic Substances”— AHRQ CCSR for ICD-10-PCS Procedures (HCUP) · v2026.1
Nearest codes
- XW03357 — Introduction of Narsoplimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7[One axis away]— CMS ICD-10-PCS tables
- XW03367 — Introduction of Terlipressin into Peripheral Vein, Percutaneous Approach, New Technology Group 7[One axis away]— CMS ICD-10-PCS tables
- XW03372 — Introduction of Inactivated Coagulation Factor Xa into Peripheral Vein, Percutaneous Approach, New Technology Group 2[One axis away]— CMS ICD-10-PCS tables
- XW03378 — Introduction of Tabelecleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 8[One axis away]— CMS ICD-10-PCS tables
- XW0337C — Introduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 12[One axis away]— CMS ICD-10-PCS tables
- XW03387 — Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7[One axis away]— CMS ICD-10-PCS tables
- XW033A7 — Introduction of Ciltacabtagene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 7[One axis away]— CMS ICD-10-PCS tables
- XW033B7 — Introduction of Amivantamab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7[One axis away]— CMS ICD-10-PCS tables
Change history (2)
- FY2027 — Removed from the code set[Change history]— CMS release files (code change ledger) · icd10pcs-fy2027
- and 1 more
Removed for FY2027 — not valid on or after October 1, 2026
Change history
Changed in FY2027, the release in force: Removed from the code set.
- FY2027 — October 1, 2026Removed from the code setIntroduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7FY2027 changes
- FY2022 — October 1, 2021Added to the code setIntroduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7FY2022 changes
Read from: CMS ICD-10-PCS code tables, index and definitions — FY2027; CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v44; AHRQ HCUP Clinical Classifications Software Refined for ICD-10-PCS Procedures (hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR_v2026-1.zip) — v2026.1. All data sources · How to read the labels · How MedCoder verifies its implementation
Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources